| Net income | 1.29M |
| Amortization of deferred acquisition costs | 6.76M |
| Acquisition costs deferred | -7.69M |
| Realized investment gains | -1.41M |
| (Decrease) increase in insurance reserves | -1.75M |
| Depreciation and amortization | 860K |
| Deferred income tax expense | 161K |
| Increase in receivables, net | -65K |
| Decrease in other liabilities | |
| Other, net | |
| Net cash (used in) provided by operating activities | |
| Proceeds from investments sold, called or matured | 9.25M |
| Investments purchased | -58.19M |
| Additions to property and equipment | -335K |
| Net cash (used in) provided by investing activities | |
| Payment of dividends on common stock | -408K |
| Purchase of shares for treasury | -565K |
| Net cash used in financing activities | |
| Net (decrease) increase in cash and cash equivalents | -3.76M |
| Cash and cash equivalents at beginning of period | 15.62M |
| Cash and cash equivalents at end of period | 11.86M |
| Cash paid for interest | 1.14M |
| Cash paid for income taxes | 675K |